MUC5B and interstitial lung disease: Although the risk score without MUC5B rs35705950 was found to be appropriate to discriminate patients with subclinical RA-ILD, the model with MUC5B rs35705950 had better performance, suggesting a slight contribution of the genetic variant to the overall risk of subclinical RA-ILD [42].